The ADC Cytotoxic Payloads / Warheads market is anticipated to grow a sustained rate, claims Roots Analysis
With six approved drugs, namely POLIVY™, LUMOXITI™,
BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300
drugs underdevelopment, antibody drug conjugates (ADCs) have emerged as a
promising class of targeted therapies for various disease indications
Roots Analysis is pleased to
announce the publication of its recent study, titled, ADC
Cytotoxic Payloads / Warheads: Products and Services Market,
2021-2030.”
The report features an extensive study on the
current market landscape, offering an informed opinion on the likely future
potential of ADC cytotoxic payloads / warheads providers, over the next decade. The study
underlines an in-depth analysis, highlighting the diverse capabilities of
various industry stakeholders engaged in this field. In addition to other
elements, the report includes:
§
A detailed assessment of the current market landscape of ADC
cytotoxic payloads / warheads.
§
A competitiveness analysis of ADC cytotoxic payloads /
warheads service providers based on various relevant parameters, featuring insightful
pictorial summaries and representations.
§
Detailed profiles of prominent ADC cytotoxic payloads /warheads service providers (shortlisted on the basis of the type of payloads
/ warheads offered).
§
An analysis of the partnerships that have been established
in this domain since 2016.
§
An insightful analysis of the patents filed / granted for ADC
cytotoxic payloads / warheads, during the period between 2016 and 2021 (till
November).
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Type of Payload
§
Payload
§
Auristatins
§
Camptothecin
§
Maytansinoids
§
Type of Product
§
Commercialized Products
§
Clinical Products
§
Key Geographical Regions
§
North America
§
Europe
§
Asia Pacific
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
§
Kevin Daley (Market Director, Novasep)
§
Floris Van Delft (Founder and Chief Scientific Officer,
Synaffix)
Key companies covered in the report
§
Abzena
§
Levana Biopharma
§
MabPlex
§
NJ Bio
§
Novasep
§
STA Pharmaceuticals
§
Synaffix
For
more information, please click on the following link:
https://www.rootsanalysis.com/reports/adc-cytotoxic-payloads-market.html
Other Recent Offerings
1.
Antibody
Drug Conjugates Market, 2021-2030
2.
Biologics
Fill / Finish Services Market, 2021-2030
3.
Global
Antibody Purification Services Market, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact:
Ben
Johnson
+1
(415) 800 3415
Ben.johnson@rootsanalysis.com
Comments
Post a Comment